Reconstruction and Computational Modelling for Inherited Metabolic Diseases

HealthHORIZON-RIAID: 101080997
EC Contribution
€78,719
Consortium Size
35 orgs
Start Year
2023
Summary

Our overall objectives are to accelerate the diagnosis, and enable personalised management, of inherited metabolic diseases (IMDs). Established academic technology for statistical genomic analysis, deep learning-based prediction of protein structure, and whole-body metabolic network modelling shall be applied to generate personalised computational models, given patient-derived genomic, transcriptomic, proteomic and metabolomic data. To train diagnostic models, a comprehensive clinical team will recruit 1,945 diagnosed patients with a wide variety of IMDs, then validate the clinical utility of personalised computational models on a set of 685 undiagnosed patients. An enhanced human metabolic network reconstruction, especially for lipid metabolism, reaction kinetics and inherited metabolic disease pathways, will increase the predictive capacity of cellular and whole-body metabolic network models. As an exemplar for other IMDs, personalised computational modelling will be used to identify compensatory and aggravating mechanisms that associate with clinical severity in Gaucher disease. The predictive capacity of personalised models will be validated by comparison with additional empirical investigations of protein structure and function as well as metabolomics, tracer-based metabolomics and proteomics of patient-derived in vitro disease models. To maximise the potential for impact, personalised modelling software will be developed to be generally applicable to a broad variety of IMDs, and implemented in a way that is both accessible to clinicians and admissible to regulatory authorities. Sustainability will be promoted by development of a roadmap for a European foundation to aid personalised diagnosis and management of IMDs, informed by broad stakeholder consultation. This is a unique opportunity to realise the potential of personalised computational modelling for a broad set of rare diseases, which is a field where European collaboration is an essential for progress.

Consortium (35)

🇮🇪 UNIVERSITY OF GALWAYIE
coordinator
🇳🇱 ACADEMISCH ZIEKENHUIS GRONINGENNL
partner
🇪🇸 ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOBIZKAIAES
partner
🇪🇸 ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOGIPUZKOAES
partner
🇮🇹 AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCSIT
partner
🇮🇹 AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALEIT
partner
🇬🇧 BELFAST HEALTH AND SOCIAL CARE TRUSTGB
partner
🇮🇪 CHILDREN'S HEALTH IRELANDIE
partner
🇮🇪 DUNDALK INSTITUTE OF TECHNOLOGYIE
partner
🇩🇪 EBERHARD KARLS UNIVERSITAET TUEBINGENDE
partner
🇳🇱 ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAMNL
partner
🇪🇸 FUNDACION PUBLICA GALEGA INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELAES
partner
🇧🇪 KATHOLIEKE UNIVERSITEIT LEUVENBE
partner
🇩🇪 KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)DE
partner
🇮🇪 MATER MISERICORDIAE UNIVERSITY HOSPITALIE
partner
🇩🇪 MEDIZINISCHE HOCHSCHULE HANNOVERDE
partner
🇦🇹 MEDIZINISCHE UNIVERSITAET WIENAT
partner
🇳🇴 OSLO UNIVERSITETSSYKEHUS HFNO
partner
🇮🇹 OSPEDALE PEDIATRICO BAMBINO GESUIT
partner
🇩🇰 REGION HOVEDSTADENDK
partner
🇨🇭 SIB SWISS INSTITUTE OF BIOINFORMATICSCH
partner
🇳🇱 STICHTING AMSTERDAM UMCNL
partner
🇬🇧 THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORDGB
partner
🇮🇹 UNIAMO - FEDERAZIONE ITALIANA MALATTIE RARE - ONLUS ASSOCIAZIONEIT
partner
🇩🇪 UNIVERSITAET OSNABRUECKDE
partner
🇩🇪 UNIVERSITAETSKLINIKUM FREIBURGDE
partner
🇩🇪 UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZDE
partner
🇳🇱 UNIVERSITAIR MEDISCH CENTRUM UTRECHTNL
partner
🇧🇪 UNIVERSITAIR ZIEKENHUIS ANTWERPENBE
partner
🇩🇪 UNIVERSITATSKLINIKUM HEIDELBERGDE
partner
🇳🇱 UNIVERSITEIT LEIDENNL
partner
🇬🇧 UNIVERSITY COLLEGE LONDONGB
partner
🇬🇧 UNIVERSITY OF NEWCASTLE UPON TYNEGB
partner
🇸🇪 VASTRA GOTALANDSREGIONENSE
partner
🇨🇿 VSEOBECNA FAKULTNI NEMOCNICE V PRAZECZ
partner